v3.25.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
ASSETS:    
Cash $ 15,633 $ 26,174
Investments:    
Marketable securities 0 0
Non-marketable securities 3,161,359 3,161,359
Total Assets 3,176,992 3,187,532
LIABILITIES AND STOCKHOLDERS’ EQUITY:    
Accounts payable and accrued expenses 52,147 62,678
Line of credit borrowings 348,843 348,843
Interest payable line of credit 52,243 45,268
Note payable and accrued interest 3,061,648 3,008,566
Total liabilities 3,514,882 3,465,355
Stockholders’ equity    
Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, $0.01 par value, 25,000,000 shares authorized, of which 3,472,491 shares are issued and outstanding as of December 31, 2024 and 3,472,491 at December 31, 2023 34,725 34,725
Additional paid-in capital 22,860,000 22,860,000
Additional paid-in capital - stock options 867,690 818,642
Accumulated deficit (25,264,274) (24,664,972)
Accumulated other comprehensive Income 1,686,543 1,196,357
Stockholders' Equity before Treasury Stock 184,684 244,752
Less: Treasury Stock, 745,536 shares, at cost (522,574) (522,574)
Total stockholders' equity (337,890) (277,822)
Total liabilities and stockholders' equity $ 3,176,992 $ 3,187,532